Unternehmen
11-50 Mitarbeitende
ImusynImusyn is a biotech company focused on alloproteomics to advance allogeneic cellular therapies. The company is primarily focused on the development and production of recombinant proteins from polymorphic genetic systems, including MHC genes, blood group genes, and many other immune response genes. The Company's proprietary recombinant protein manufacturing technology meets the needs of customers in the medical and life science markets for advanced diagnostics and immunotherapies.
Adresse
Feodor-Lynen-Straße 5, 30625 Hannover, Deutschland
Handelsregister
GmbH & Co. KG